Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;29(6):539-551.
doi: 10.1016/j.jsps.2021.04.015. Epub 2021 Apr 22.

GPCRs: The most promiscuous druggable receptor of the mankind

Affiliations
Review

GPCRs: The most promiscuous druggable receptor of the mankind

Khaled Alhosaini et al. Saudi Pharm J. 2021 Jun.

Abstract

All physiological events in living organisms originated as specific chemical/biochemical signals on the cell surface and transmitted into the cytoplasm. This signal is translated within milliseconds-hours to a specific and unique order required to maintain optimum performance and homeostasis of living organisms. Examples of daily biological functions include neuronal communication and neurotransmission in the process of learning and memory, secretion (hormones, sweat, and saliva), muscle contraction, cellular growth, differentiation and migration during wound healing, and immunity to fight infections. Among the different transducers for such life-dependent signals is the large family of G protein-coupled receptors (GPCRs). GPCRs constitute roughly 800 genes, corresponding to 2% of the human genome. While GPCRs control a plethora of pathophysiological disorders, only approximately one-third of GPCR families have been deorphanized and characterized. Recent drug data show that around 40% of the recommended drugs available in the market target mainly GPCRs. In this review, we presented how such system signals, either through G protein or via other players, independent of G protein, function within the biological system. We also discussed drugs in the market or clinical trials targeting mainly GPCRs in various diseases, including cancer.

Keywords: AC, Adenylyl Cyclase; Arrestin; CCR, Chemokine Receptor; COX, Cyclooxygenase; DAG, Diacylglycerol; Drugs; ERK, Extracellular signal-Regulated Kinase; G proteins; GIP, Gastric Inhibitory Peptide; GLP1R, Glucagon-Like Peptide-1 Receptor; GPCR; GRKs; GRKs, G protein-coupled Receptor Kinases; Heterodimerization; IP3, Inositol 1,4,5-triphosphate; MAPK, Mitogen-Activated Protein Kinase; NMDA, N-Methyl D-Aspartate; Nbs, Nanobodies; PAR-1, Protease Activated Receptor 1; PIP2, Phosphatidylinositol-4,5-bisphosphate; PKA, Protein Kinase A; Signaling; cAMP, cyclic AMP.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Flowchart showing the classification of GPCRs superfamily. Approximately 826 GPCRs members can be classified into five classes according to seven-transmembrane domain sequence homology (Fredriksson et al., 2003, Langenhan, 2020).
Fig. 2
Fig. 2
Schematic diagram of GPCRs signaling steps, A)- G protein-dependent signaling; Following binding of agonist to the extracellular domain of receptor results in conformation change of receptor including cytosolic c-Terminus leading to recruit specific heterotrimeric G protein. Exchange of GDP by GTP of Gα subunit (Gαq, Gαs, Gαi, and Gα12/13) results in dissociation of heterotrimeric G proteins and downstream signaling of Gα from βγ. B)- G protein independent signaling; Following termination of first wave signals by PKC, PKA, or GRKs that lead to β-Arrestins recruitment to c-terminus of the receptor. β-Arrestins will prevent further G proteins coupling, facilitate internalization of receptor and act as a scaffold for MAP kinase signaling as a second signal wave.

References

    1. Ahmed, A.A.M.A., 2019. Antiplatelet drug management. In: Patient Blood Management in Cardiac Surgery. Springer, 51–60.
    1. Akhter S.A., D'Souza K.M., Petrashevskaya N.N., Mialet-Perez J., Liggett S.B. Myocardial beta1-adrenergic receptor polymorphisms affect functional recovery after ischemic injury. Am. J. Physiol. Heart Circ. Physiol. 2006;290:H1427–H1432. - PubMed
    1. Alexander S.P., Benson H.E., Faccenda E., Pawson A.J., Sharman J.L., Spedding M., Peters J.A., Harmar A.J., Collaborators C. The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br. J. Pharmacol. 2013;170:1459–1581. - PMC - PubMed
    1. Alvarez-Curto E., Inoue A., Jenkins L., Raihan S.Z., Prihandoko R., Tobin A.B., Milligan G. Targeted elimination of G proteins and arrestins defines their specific contributions to both intensity and duration of G Protein-coupled Receptor Signaling. J. Biol. Chem. 2016;291:27147–27159. - PMC - PubMed
    1. Andrews G., Jones C., Wreggett K.A. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5. Mol. Pharmacol. 2008;73:855–867. - PubMed